Ansøgningsnr. og dato | 13849992.6 (espacenet) (Federated) (European Patent Register), 20131210 | Patent/reg.nr. og dato | DK/EP 2931745, 20180822 | Tilgængelighedsdato | 20151021 | Prioritetsnr. og dato | US 201261735823 P, 20121211 | EP publ. nr. og dato |
EP 2931745 20151021 | Løbedag | | Ansøger/indehaver | MedImmune Limited, Milstein Building Granta Park
Cambridge CB21 6GH, GB | Ansøgers ref. nr. | MedImmune Limited GLPGG-100 | Opfinder | AGORAM, Balaji, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, ANTONSSON, Madeleine, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, BEDNAREK, Maria, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, BURMEISTER, Nicole, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, BENTHEM, Lambertus, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, FAIRMAN, David, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, FRITSCH-FREDIN, Maria, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, JACKSON, Ronald, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, LOFMARK, Rasmus, Jansson, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB, METCALFE, Jacqueline, C/o Medimmune Limited Milstein Building Granta Park
Cambridge CB21 6GH, GB | Fuldmægtig | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB, GB | Interessent på tilknyttet sag | | IPC-Klasse | C07K 14/435 (2006.01) | Titel/benævnelse | GLUCAGON/GLP-1-AGONISTER TIL BEHANDLING AF OBESITAS | Internationalt ansøgningsnr. | IB2013003191 | Internationalt publ. nr. | WO2014091316 | Relateret sag (certifikat) | | Status | DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|